XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia.
about
Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia.DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies.Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.Pharmacogenomics and the treatment of acute myeloid leukemia.The Arg399Gln polymorphism in the XRCC1 gene is associated with increased risk of hematological malignancies.Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.
P2860
Q33735802-ED240BB4-1B5D-4BD3-ABD5-9672061C6FE3Q38238954-D0982BBE-468A-4D15-8B72-321E00DB9BEDQ38648332-CD18A24F-93DB-46F8-90E4-70F442B439BDQ38694866-9AA276B3-0124-422E-A59D-53BF3454DF11Q38887034-D75520F6-8011-41A2-A1E4-35CDA60593DEQ39050324-C9AA182E-AC4F-4002-9423-6502354A1A1BQ39942266-3618694E-85EC-4FDD-BE2A-808FE9490091Q40650613-844074F9-CA1C-43BE-B807-D0ECACC2A726Q45366315-26B87476-FB0E-4101-906A-F6724E44B5D4Q50567640-3A8E2C80-68ED-48C9-A6D2-6758CF17C4E6Q55460803-87BC7F3F-4444-471B-AF0C-F3B11372A11E
P2860
XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
XRCC1 Arg194Trp and Arg399Gln ...... val in acute myeloid leukemia.
@en
XRCC1 Arg194Trp and Arg399Gln ...... val in acute myeloid leukemia.
@nl
type
label
XRCC1 Arg194Trp and Arg399Gln ...... val in acute myeloid leukemia.
@en
XRCC1 Arg194Trp and Arg399Gln ...... val in acute myeloid leukemia.
@nl
prefLabel
XRCC1 Arg194Trp and Arg399Gln ...... val in acute myeloid leukemia.
@en
XRCC1 Arg194Trp and Arg399Gln ...... val in acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
XRCC1 Arg194Trp and Arg399Gln ...... val in acute myeloid leukemia.
@en
P2093
Adrian P Trifa
Carmen Duicu
Claudia Bănescu
Minodora Dobreanu
P2860
P304
P356
10.3109/10428194.2013.802781
P577
2013-06-14T00:00:00Z